Guild Update – 29 March 16 : National Rollout: MedsASSIST – Informing Medicine Decisions
March 29, 2016
THE national rollout of
MedsASSIST is now underway. It’s
the new real-time recording and
monitoring system for medicines
containing codeine, which will
benefit consumers and the
pharmacy profession.
MedsASSIST was developed in
response to concerns over patient
safety relating to these medicines
and as an effective alternative to
making them prescription-only.
MedsASSIST aims to ensure that
the majority of consumers who
use these medicines safely can
continue to access them at their
local pharmacy.
MedsASSIST is a clinical decision
support system designed to help
pharmacists identify consumers
who are at risk of codeine
dependence.
MedsASSIST will be delivered
to all pharmacies by mid-April.
Pharmacies will receive an email
with an individual username and
password to log in to the system
and access support materials for
implementation in the pharmacy.
This is a vital project for our
profession. MedsASSIST will
only be effective if pharmacists
and pharmacy staff support it
nationally and the Guild urges all
pharmacies across Australia to
implement it.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Mar 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.